In this article, Sharon Hartles explores the UK’s delayed response to the Diethylstilbestrol DES drug scandal. Despite mounting evidence of harm, survivors were left without answers, support, or accountability. Sharon calls on the government to go beyond a limited investigation and urges a formal apology, a public inquiry, and the creation of a compensation scheme.